Immunization Safety Review: Vaccines and Autism (2004)

Chapter: Appendix C: Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2003, 2004)

Previous Chapter: Appendix B: Public Meeting Agenda February 9, 2004
Suggested Citation: "Appendix C: Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2003, 2004)." Institute of Medicine. 2004. Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.

Appendix C
Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2003, 2004)

Suggested Citation: "Appendix C: Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2003, 2004)." Institute of Medicine. 2004. Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.

TABLE C-1 Mercury Content from Thimerosal in the Routinely Recommended Pediatric Vaccines1 in the United States, April 2004

Vaccine

Brand Name

Manufacturer

Hg [μg/dose]

DTaP

(Diphtheria and tetanus toxoids and acellular pertussis)

Tripedia

Aventis Pasteur, Inc.

≤0.3

Infanrix

Glaxo-SmithKline

0

Daptacel

Aventis Pasteur, Ltd

0

Td1

(Tetanus and diphtheria toxoids)

None

Aventis Pasteur, Inc.

25

Decavac

Aventis Pasteur, Inc.

= 0.3

None

Aventis Pasteur, Ltd

0

None

Mass Public Health

8.3

DTaP-Hib

(Diphtheria and tetanus toxoids with acellular pertussis combined with Haemophilus influenzae type b)

TriHIBit2

Aventis Pasteur

≤0.3

Hib

(Haemophilus influenzae type b)

ActHIB/OmniHib

Aventis Pasteur, SA

0

HibTITER (Single dose)

Wyeth-Lederle

0

PedvaxHIB liquid

Merck

0

Hib/HepB (Haemophilus influenzae type b combined with Hepatitis B )

COMVAX

Merck

0

Hep B

(Hepatitis B)

(pediatric formulation)

Engerix B

Glaxo-SmithKline

<0.5

Recombivax HB

Merck

0

Influenza

Fluzone3

Aventis Pasteur, Inc.

12.5

Fluzone

Aventis Pasteur, Inc.

≤0.5ug/

(Preservative Free)

 

0.25mL dose

Pneumococcal

Prevnar

(pneumoconjugate)

Wyeth

0

IPV

(Inactivated polio vaccine)

IPOL

Aventis Pasteur, SA

0

Poliovax

Aventis Pasteur, Ltd.

0

MMR

(Measles, mumps, and rubella)

MMR-II

Merck

0

Varicella

Varivax

Merck

0

1Licensed for persons 7 years of age and older.

2For use in children 15 to 18 months of age.

3Influenza vaccine is recommended for children 6-23 months of age. MMWR (2004) 52:1-4; MMWR (2004) 53:1-3.

Suggested Citation: "Appendix C: Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2003, 2004)." Institute of Medicine. 2004. Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.

TABLE C-2 Mercury Content from Thimerosal in the Currently Licensed Vaccines That Are Recommended for Some Children in the United States, April 2004

Vaccine

Brand Name

Manufacturer

Hg [μg/dose]

DT

(Diphtheria and tetanus toxoids)

All Products

Aventis Pasteur, Inc. (single dose)

0.3

 

Aventis Pasteur, Inc. (multi-dose)

25

 

Aventis Pasteur, Ltd*

25

TT (Tetanus Toxoid)

All Products

Aventis Pasteur, Inc.

25

Pneumococcal Polysaccharide

Pneumovax 23

Merck

0

Hepatitis A

Havrix

Glaxo-SmithKline

0

Vaqta

Merck

0

Influenza

Fluzone1

Aventis Pasteur, Inc.

25

Fluzone

(Preservative free)

Aventis Pasteur, Inc.

≤1 μg/0.5 mL

dose or ≤0.5 μg/

0.25 mL dose

Fluvirin

Evans

25

Fluvirin

Evans

<1 μg

Influenza, Live

FluMist

MedImmune

0

*Not available in the United States.

1Children under 3 years of age received half of a vaccine dose (0.25 mL or 12.5 μg mercury/dose).

Suggested Citation: "Appendix C: Thimerosal Content in Licensed Vaccines (Adapted from FDA, 2003, 2004)." Institute of Medicine. 2004. Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.

TABLE C-3 Mercury Content from Thimerosal in Other Licensed Vaccines in the United States, April 2004

Vaccine

Brand Name

Manufacturer

Hg [μg/dose]

Anthrax

BioThrax

BioPort Corporation

0

Smallpox

Dryvax

Wyeth

0

BCG*

 

Organon Tecknika

0

Mycobax

Aventis Pasteur, Ltd

0

Hepatitis A-Hepatitis B

Twinrix

Glaxo-SmithKline

<1 μg

Hepatitis B

Engerix B

(adult formulation)

Glaxo-SmithKline

< 0.5

 

Recombivax HB

(adult formulation)

Merck

25

 

Recombivax HB

(adult formulation)

Merck

0

Lyme*

LYMErix

Glaxo-SmithKline

0

Meningococcal1

Menomune A, C,

AC and A/C/Y/W-135

Aventis Pasteur, Inc.

(multidose)

25

 

Single dose

0

Rabies

IMOVAX

Aventis Pasteur SA

0

Rabavert

Chiron Behring

0

Typhoid Fever

Typhim Vi

Aventis Pasteur SA

0

Vivotif Berna

Berna Biotech, Ltd.

0

Yellow Fever

YF-VAX

Aventis Pasteur, Inc.

0

Japanese Encephalitis Vaccine

JE-VAX

Aventis Pasteur, Inc.

35

*Not available in the United States.

1Menomune A/C/Y/W-135, a thimerosal-containing vaccine, is not indicated for infants and children younger than 2 years of age except as short-term protection of infants 3 months and older against Group A. (Physician’s Desk Reference, 2001).

Next Chapter: Appendix D: Chronology of Important Events Regarding Vaccine Safety
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.